MedTrace Logo

Comparison of Enteral Versus Parenteral Feeding in Healthy Human Subjects

NCT00856219 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2015-05-22

No results posted yet for this study

Summary

Literature suggests that route of feeding and/or certain nutrients may cause alterations in the body's immune cells. Immune cells help protect the body and fight infection/disease. Tube feeding (TF) is a method of delivering nutrition directly to the stomach/intestines via a small tube. The immune system may respond differently when receiving continuous TF as compared to receiving intermittent TF. Heart rate variability (HRV, the intervals between heartbeats) is a measurement of the nervous system's response to a stress/illness. The differences in immune cells and/or HRV may influence how the body reacts to complications such as infection.

Conditions

  • Healthy

Interventions

DIETARY_SUPPLEMENT

Enteral Continuous

Continuous Tube Feeding for 72 hours

DIETARY_SUPPLEMENT

Enteral Intermittent

Intermittent Tube Feedings

DIETARY_SUPPLEMENT

Parenteral Continuous

Parenteral Continuously for 72 hours

Sponsors & Collaborators

  • Rutgers, The State University of New Jersey

    lead OTHER

Principal Investigators

  • Siobhan Corbett, MD · Rutgers-RWJMS

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-02-28
Primary Completion
2011-03-31
Completion
2011-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00856219 on ClinicalTrials.gov